In a significant step toward global growth, Indian medical technology firm Remidio is setting its sights on the US and European markets, with fresh backing from Boundary Holding, a deep-tech investment firm founded by venture capitalist Rajat Khare.
Remidio has gained recognition for revolutionizing eye care by developing AI-integrated, user-friendly ophthalmic devices that facilitate early detection of vision-threatening conditions such as cataract, retinal diseases, glaucoma, and refractive errors. These proprietary tools have already impacted millions, particularly in under-resourced regions where access to ophthalmologists is limited.
With the global population aging rapidly, the demand for comprehensive eye care is rising sharply. Studies suggest that a large portion of vision loss is avoidable with early detection, and this is precisely where Remidio excels. Its portable, affordable, and intuitive screening devices are designed to be used by healthcare workers, technicians, and even trained volunteers with minimal expertise — making quality eye testing accessible in remote villages, public health centers, and even retail environments like supermarkets.
Remidio’s founder Anand Sivaraman met Rajat Khare during a visit to India. The alignment in vision and shared commitment to tech-driven impact inspired Khare to back the company through Boundary Holding, which specializes in funding innovations that contribute to the Fourth Industrial Revolution.
“I could instantly connect with Anand’s passion and long-term vision,” said Khare. “Remidio’s approach is a compelling blend of social impact and scalable technology — the kind of disruption that defines the future of global healthcare.”
The capital infusion from Boundary Holding will enable Remidio to scale its research and development capabilities, strengthen its marketing and sales infrastructure, and pursue strategic acquisitions and partnerships in Western markets. This expansion marks a pivotal milestone in the company’s journey to globalize its mission of eliminating avoidable blindness.
Boundary Holding, under Rajat Khare’s leadership, continues to support deep-tech companies operating at the intersection of AI, medical innovation, and real-world impact. Known for its sharp focus on scalable, high-tech solutions, the firm plays a crucial role in transforming emerging technologies into global success stories.
As Remidio prepares to launch into new geographies, its mission remains crystal clear: empower early disease detection and make eye care accessible for all. In a world where millions suffer due to preventable vision loss, this partnership has the potential to open eyes — and doors — to a brighter, clearer future.
Business Minds: Inspiring Stories of Visionaries 
Leave a comment